Adherent Cells Generated during Long-Term Culture of Human Umbilical Cord Blood CD34+ Cells have Characteristics of Endothelial Cells and have Beneficial Effect on Cord Blood Ex-Vivo Expansion.  STEM CELLS. 2003.
 Mobilization Kinetics of CD34+ cells in association with modulation of CD44 and CD31 expression during continuous intravenous administration of G-CSF in normal donors.  STEM CELLS. 2000.
 Putative chromosomal deletions on 9p, 9q and 22q occur preferentially in malignant gastrointestinal stromal tumors.  Int J. Cancer. 2000.
 Early detection of relapse by hypermetaphase FISH after allogeneic BMT for CML.  J. Clin Oncol. 2000.
 Analysis of Philadelphia chromosome-negative BCR-ABL-positive chromic myelogenous leukemia by hypermetaphase fluorescence in situ hybridization.  Ann Oncol. 1999.
 Distinct patterns of apoptosis in association with modulation of CD44 induced by thrombopoietin and granulocyte-colony stimulating factor during ex-vivo expansion of human cord blood CD34+ cells.  British Journal of Haematology. 1999.
 Myeloid Differentiation of Human Cord Blood CD34+ Cells during ex vivo Expansion using Thrombopoietin, Flt3-ligand, and/or Granulocyte-Colony Stimulating Factor.  British Journal of Haematology. 1999.
 Philadelphia Chromosome-positive Myeloid Cells in the Peripheral Blood of CML Patients: Comparison with Frequency Detected in Cycling Cells of the Bone marrow.  Clinical cancer Research. 1998.
 Prognostic value of cytogenetics in multiple myeloma.  Br. J. Hematology. 1998.
 Usefulness of Detection of Minimal Residual Disease by hypermetaphase fluorescent in situ hybridization after allogeneic BMT for CML.  BMT. 1997.
 Mobilization kinetics of CD34+/Thy-1dim progenitor during rhG-CSF stimulation in normal donors.  Transfusion. 1997.
 Progressive multifocal leukoencephalopathy (PML) after autologous bone marrow transplantation in a patient with chronic myelogenous leukemia.  Clinical Infectious Disease. 1996.
 Hypermetaphase fluorescence in situ hybridization(FISH) for quantitative monitoring of ph-positive cells in chronic myelogenous leukemia(CML) during treatment.  Blood. 1995.
 Analysis of interphase cells for the Philadelphia Chromosome(Ph)- translocation using painting probes made by inter-Alu Polymerase Chain Reaction(PCR).  Blood. 1994.
 Leptomeningeal toxoplasmosis after allogeneic marrow transplantation.  Amer J Clin Oncol. 1993.
 Detection of variant Ph1-positive chronic myelogenous leukemia (CML) involving chromosome #1, #9, and #22 by fluorescence in site hybridizaton.  Cancer Genet Cytogenet. 1993.
 Identification of a complex formed between nuclear proteins and the transcriptional enhancer of interferon-inducible genes which is present in the peripheral blood myeloid cells of CML but not normal individuals.  J Interferon Res. 1992.
 activation of class I HLA expression is mediated by TNF-alpha and gamma-interferon through protein kinase C-dependent pathway in CML cell lines.  Br J Haemato. 1991.
 Regulation of gene expression by tumor necrosis factor-alpha and interferon-gamma in chronic myelogenous leukemia.  Trans Assoc Am Physicians. 1990.
 A phosphatase activity present in peripheral blood myeloid cells of CML patients but normal individuals alters nuclear protein binding to transcriptional enhancers of interferon-inducible genes.  J Clin Invest. 1990.